Business Context and Reporting Period
Company: Achieve Life Sciences, Inc. (ACHV)
Filing Type: Form 8-K (Current Report)
Report Date: May 9, 2024
Reporting Period: First Quarter ended March 31, 2024
This filing serves as a notification that the company issued a press release on May 9, 2024, announcing its financial results for the first quarter of 2024. The detailed results are contained in Exhibit 99.1.
Key Financial Metrics
The provided text is a cover sheet for the Form 8-K and does not contain specific financial data. The filing explicitly states that the detailed results of operations and financial condition are furnished in the attached press release (Exhibit 99.1). Therefore, the following metrics are not available in this text:
- Revenue
- Profit/Loss
- Cash Flow
- Margins
- Debt and Liquidity
Note: The filing text does not provide a clear value for any specific financial metric.
Material Changes
No material changes versus the prior comparable period are described in this document. The document solely references the issuance of the Q1 2024 results press release.
Guidance, Outlook, and Risks
This filing does not contain management commentary, forward-looking guidance, risk factors, or details on contingencies. These items, if present, would be located in the referenced press release (Exhibit 99.1).
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated May 9, 2024) for actual Q1 2024 revenue, net loss, and cash burn figures.
- Verify the company's liquidity position and runway as detailed in the full press release.
- Check for any updates on clinical trial progress or regulatory milestones mentioned in the full announcement.
- Confirm if the company provided updated full-year 2024 guidance in the press release.